Healthcare >> Analyst Interviews >> June 4, 2001
IAN SANDERSON is a Managing Director of SG Cowen and is responsible for
coverage of emerging and mid-cap pharmaceutical companies including
specialty pharmaceutical, drug delivery, and generic pharmaceutical
companies. His prior experience includes investment banking at SG Cowen
and Houlihan Lokey Howard & Zukin; securities analysis at Cambridge
Associates and Putnam International Advisors; and systems design at U.S.
Surgical Corporation. He received a BA in Political Economy from
Williams College and an MBA in Finance from the Wharton School at the
University of Pennsylvania. Profile
TWST: Will you bring us up to date in terms of the developments andannouncements ' the milestones, if you will 'that have been particularly
significant for specialty pharma, generics and drug